Limei Poon
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lymphoma Diagnosis and Treatment 12
- Oncology 10
- Viral-associated cancers and disorders 5
- CAR-T cell therapy research 2
- Co-authors
- Seok Jin Kim (1 shared paper)Florence Loong (1 shared paper)Eric Tse (2 shared papers)Benjamin Mow (1 shared paper)Yok‐Lam Kwong (1 shared paper)Thomas S. Y. Chan (1 shared paper)Jabed Iqbal (1 shared paper)Pek‐Lan Khong (1 shared paper)
- Journals
- Bone Marrow Transplantation (3 papers)Blood (2 papers)Nature Medicine (1 paper)British Journal of Haematology (1 paper)Blood Cancer Journal (1 paper)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Limei Poon
21 papers receiving 544 citations
Limei Poon's Hit Papers
Peers
Comparison fields: 5 of 38
- Pathology and Forensic Medicine 332
- Oncology 367
- Immunology 260
- Hematology 94
- Genetics 65
Countries citing papers authored by Limei Poon
This map shows the geographic impact of Limei Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Poon more than expected).
Fields of papers citing papers by Limei Poon
This network shows the impact of papers produced by Limei Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Poon. The network helps show where Limei Poon may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Poon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase Hit paper breakdown → | 2017 | 359 |
| 2 | 2012 | 33 | |
| 3 | Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. | 2013 | 29 |
| 4 | 2020 | 28 | |
| 5 | 2024 | 26 | |
| 6 | 2008 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2017 | 11 | |
| 9 | 2023 | 5 | |
| 10 | 2020 | 5 | |
| 11 | Occult respiratory viral infections in coronial autopsies: a pilot project. | 2009 | 5 |
| 12 | 2024 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2007 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Limei Poon
Limei Poon is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Immunology, having authored 23 papers that have together received 552 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), T-cell and Retrovirus Studies (3 papers), Acute Lymphoblastic Leukemia research (2 papers), CAR-T cell therapy research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (332 citations), Oncology (367 citations), Immunology (260 citations), Hematology (94 citations) and Genetics (65 citations). Limei Poon has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Seok Jin Kim, Florence Loong, Eric Tse, Benjamin Mow, Yok‐Lam Kwong, Thomas S. Y. Chan, Jabed Iqbal, Pek‐Lan Khong, Daryl Tan and Colin Phipps. Their work appears in journals such as Bone Marrow Transplantation, Blood, Nature Medicine, British Journal of Haematology and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.